Dr Reddy’s Laboratories reported a sharp 86% year-on-year fall in consolidated net profit to Rs 221 crore for the March-ended quarter. Revenue also declined 12%, adding pressure to the business outlook. Despite the steep profit drop, the company announced a dividend of Rs 8 per share, offering a small positive for investors.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
